Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01957228
Other study ID # 2013-A00960-45
Secondary ID 2013-28
Status Completed
Phase N/A
First received
Last updated
Start date October 7, 2013
Est. completion date October 26, 2022

Study information

Verified date April 2023
Source Assistance Publique Hopitaux De Marseille
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

On joint orthopaedic hardware infections are one of the most frequently encountered complications in orthopaedic surgery. However 6% of the cultures remain sterile, etiological diagnosis cannot be established despite obvious signs of infection. As part of this research project, we have developed a new strategy diagnosis including directly the use of PCR to reduce the number of negative results. This should have a major therapeutic impact in terms of timeliness and specificity of antibiotic. Primary: Evaluate the effectiveness of the new diagnostic strategy on etiological identification of prosthesis infections. Hypothesis: Minimum 6 percent increase in the number of patients with an etiological diagnosis of infection on prosthesis.


Recruitment information / eligibility

Status Completed
Enrollment 980
Est. completion date October 26, 2022
Est. primary completion date September 30, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patient is more than 18 years old. - Patient with a prescription of a microbiologic diagnostic of Prosthetic joint infection - Patient who do not declined to have his medical records reviewed for research - Patient with health insurance Exclusion Criteria: - Patient minor (<18 years). - Pregnant or lactating woman. - Major under guardianship Patient. - Patient deprived of liberty or under court order

Study Design


Intervention

Procedure:
bone biopsies


Locations

Country Name City State
France Assistance Publique Hopitaux de Marseille Marseille

Sponsors (1)

Lead Sponsor Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Bone biopsies multisite Increase of at least 6% of patients with an etiologic diagnosis of prosthesis infection established. 4 years
See also
  Status Clinical Trial Phase
Recruiting NCT03769337 - New Markers for Diagnosis of Prosthetic Infections
Terminated NCT01705496 - [124I]FIAU PET-CT Scanning in Patients With Pain in a Prosthetic Knee or Hip Joint Phase 2